• Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Withou... AOL.com Thu, 09 Jul 2026 01:21:46 GMT
• agenus and noetik present asco 2026 data linking ai analysis of routine pretreatment tumor pathology images to response and surviv... AOL.com Tue, 07 Jul 2026 23:24:55 GMT
• Form 4 Agenus Inc For: 7 July By Investing.com Investing.com Nigeria Tue, 07 Jul 2026 15:08:30 GMT
• Agenus (NASDAQ: AGEN) director Harrison awarded 8,547 shares as board compensation Stock Titan Tue, 07 Jul 2026 14:48:42 GMT
• Director Wright of Agenus (NASDAQ: AGEN) granted deferred stock units Stock Titan Tue, 07 Jul 2026 14:42:03 GMT
• Agenus’ metastatic colorectal cancer combo achieves 33% three-year OS rate Clinical Trials Arena Tue, 07 Jul 2026 09:04:06 GMT
• Agenus Inc. Amends Notes and Issues New Warrants in 2026 Definitive Agreement – Key Details and Terms Minichart Tue, 07 Jul 2026 01:40:00 GMT
• Agenus Extends $5.09M Notes to 2027, Lengthens Warrants to 2031 and Issues New D Warrants TradingView Mon, 06 Jul 2026 20:13:02 GMT
• Agenus (NASDAQ: AGEN) extends note maturity and long-dated warrants Stock Titan Mon, 06 Jul 2026 20:11:35 GMT
• Agenus Reports Landmark 3-Year OS Data for BOT+BAL in Refractory MSS mCRC at ESMO GI Oncodaily Mon, 06 Jul 2026 19:09:08 GMT
• Agenus BOT+BAL Shows 33% Three-Year Survival in Immunotherapy-Resistant Colorectal Cancer BioPharm International Mon, 06 Jul 2026 18:38:21 GMT
• BOT+BAL Continues to Show Durable Clinical Benefit in MSS mCRC – Agenus Oncodaily Mon, 06 Jul 2026 18:27:10 GMT
• Agenus (AGEN) Reports Promising Data on BOT/BAL Therapy for Colo GuruFocus Mon, 06 Jul 2026 18:22:30 GMT
• Agenus’ metastatic colorectal cancer combo achieves 33% three-year OS rate Yahoo Mon, 06 Jul 2026 17:04:58 GMT
• Agenus reports 3-year survival data in colorectal cancer study grafa.com Mon, 06 Jul 2026 15:44:00 GMT
• Agenus reports 3-year survival data for colorectal cancer therapy Investing.com Mon, 06 Jul 2026 12:36:16 GMT
• Agenus (AGEN) Reports Promising Long-Term Survival Data for BOT+ GuruFocus Mon, 06 Jul 2026 12:19:50 GMT
• Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Withou... lincolnjournal.com Mon, 06 Jul 2026 11:30:00 GMT
• form 4 agenus inc for: 30 june by investing.com Investing.com Australia Tue, 30 Jun 2026 10:36:17 GMT
• Agenus (AGEN) director Armen takes June 2026 salary in 5,364 company shares Stock Titan Tue, 30 Jun 2026 10:06:39 GMT
• Agenus Inc.(NasdaqCM: AGEN) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:10:26 GMT
• Agenus Inc.(NasdaqCM: AGEN) added to Russell 2000 Index marketscreener.com Mon, 29 Jun 2026 18:27:53 GMT
• Agenus Inc.(NasdaqCM: AGEN) added to Russell 2500 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 16:15:49 GMT
• Agenus Inc.(NasdaqCM: AGEN) added to Russell 3000E Value Benchmark marketscreener.com Mon, 29 Jun 2026 09:24:01 GMT
• durable outcomes in mss metastatic colorectal cancer without active liver metastases - agenus Oncodaily Fri, 26 Jun 2026 21:19:06 GMT
• enterprise value to revenue forward of agenus inc. – nasdaq:agen TradingView Fri, 26 Jun 2026 09:36:46 GMT
• Updated Long-Term Follow-Up From the Phase 1b BOT+BAL Study at ESMO GI 2026 - Agenus Oncodaily Thu, 25 Jun 2026 21:54:14 GMT
• agenus challenges 'untreatable' status of a common colorectal cancer BriefGlance Thu, 25 Jun 2026 11:00:00 GMT
• agenus bot+bal study adds 3-year survival data in colorectal cancer Stock Titan Thu, 25 Jun 2026 11:00:00 GMT
• Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO ... Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• Agenus to present 3-year cancer trial data at ESMO conference Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• agenus (agen) set to present promising survival data at esmo 202 GuruFocus Thu, 25 Jun 2026 07:00:00 GMT
• agenus inc (agen) financial health: profitability & balance sheet analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• agenus inc. files form 8-k with sec: corporate details, stock information & key disclosures (june 16, 2026) 25 Minichart Tue, 23 Jun 2026 15:37:00 GMT
• form 8k agenus inc for: 23 june by investing.com Investing.com South Africa Tue, 23 Jun 2026 14:35:31 GMT
• Agenus (NASDAQ: AGEN) investors approve equity plan changes and KPMG Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agenus inc (agen) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 19 Jun 2026 04:57:33 GMT
• agenus inc (agen) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 10:23:34 GMT
• agenus inc (agen) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 10:17:14 GMT
• agenus inc (agen) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• agenus inc (agen) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• agenus inc (agen) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• agenus inc (agen) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 04:53:26 GMT
• agenus inc (agen) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 04:26:24 GMT
• agenus inc (agen) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 04:26:21 GMT
• agenus inc (agen) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 04:21:41 GMT
• agenus inc (agen) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 04:21:34 GMT
• evolution of increased longevity and slowed ageing in a genus of tropical butterfly Nature Wed, 17 Jun 2026 02:34:19 GMT
• agenus annual meeting: bot/bal leads cancer drug push as balance sheet improves TradingView Tue, 16 Jun 2026 16:06:27 GMT
• Agenus (NASDAQ: AGEN) pays Dr. Garo Armen salary in stock grant Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• evolution of increased longevity and slowed ageing in a genus of tropical butterfly Nature Tue, 16 Jun 2026 07:00:00 GMT
• Why Is Agenus (AGEN) Down 9.6% Since Last Earnings Report? Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• Is Agenus Stock a Hold Amid Valuation and Funding Risks? Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• AGEN Early Access Revenues Signal a New Path Ahead of Approval TradingView Fri, 05 Jun 2026 07:00:00 GMT
• progressing immunotherapy advances for patients with difficult-to-treat cancers – agenus Oncodaily Wed, 03 Jun 2026 19:35:28 GMT
• deadline alert: faruqi & faruqi, llp investigates claims on behalf of investors of agenus TMX Newsfile Tue, 02 Jun 2026 15:31:46 GMT
• Shareholders to log in as Agenus holds 2026 annual meeting online Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• Garo H. Armen of Agenus (NASDAQ: AGEN) receives 4,644-share stock salary grant Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• agenus announces virtual 2026 annual shareholders meeting Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• agen stock price, quote & chart | agenus inc (nasdaq:agen) ChartMill Mon, 01 Jun 2026 07:00:00 GMT
• agenus (agen) earnings expected to grow: what to know ahead of q1 release MSN Sat, 30 May 2026 02:51:28 GMT
• AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential? Zacks Investment Research Thu, 28 May 2026 07:00:00 GMT
• agen technical analysis | trend, signals & chart patterns | agenus inc (nasdaq:agen) ChartMill Wed, 27 May 2026 07:00:00 GMT
• How Agenus' Pipeline Progress Unlock Its Next Growth Phase Yahoo Finance Tue, 26 May 2026 07:00:00 GMT
• Agenus: Weighing The Clinical Progress Against The Company's Cash (NASDAQ:AGEN) Seeking Alpha Tue, 26 May 2026 07:00:00 GMT
• agenus: weighing the clinical progress against the company’s cash (nasdaq:agen) Seeking Alpha Mon, 25 May 2026 07:00:00 GMT
• agenus reports melanoma trial data for checkpoint therapy by investing.com Investing.com South Africa Fri, 22 May 2026 10:07:04 GMT
• Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Surviv... BioSpace Fri, 22 May 2026 07:00:00 GMT
• h.c. wainwright maintains agenus(agen.us) with buy rating, maintains target price $23 Moomoo Fri, 22 May 2026 07:00:00 GMT
• agenus presents phase 2 bot+bal melanoma data showing durable responses and meaningful survival in advanced checkpoint-refractory ... BioSpace Fri, 22 May 2026 07:00:00 GMT
• bot+bal demonstrates durable immune benefit in advanced melanoma – agenus Oncodaily Fri, 22 May 2026 07:00:00 GMT
• new melanoma drug combo sees 42% of patients alive at 2 years Stock Titan Thu, 21 May 2026 21:00:00 GMT
• AGEN Stock Dips 19.4% in a Month: Time to Buy, Hold or Sell? TradingView Thu, 21 May 2026 07:00:00 GMT
• agenus reports melanoma trial data for checkpoint therapy Investing.com Thu, 21 May 2026 07:00:00 GMT
• agenus and noetik present asco 2026 data linking ai analysis of routine pretreatment tumor pathology images to response and surviv... Yahoo Finance Thu, 21 May 2026 07:00:00 GMT
• agen technical analysis | trend, signals & chart patterns | agenus inc (nasdaq:agen) ChartMill Wed, 20 May 2026 07:00:00 GMT
• agenus announces publication of phase 1b botensilimab and balstilimab data in post-immunotherapy hepatocellular carcinoma in liver... BioSpace Mon, 18 May 2026 01:55:54 GMT
• agenus announces publication of phase 1b botensilimab and balstilimab data in post-immunotherapy hepatocellular carcinoma in liver... BioSpace Sun, 17 May 2026 07:00:00 GMT
• agenus (agen) reports phase 1b results for innovative cancer tre GuruFocus Sat, 16 May 2026 05:34:14 GMT
• agenus announces resignation of principal accounting officer TipRanks Fri, 15 May 2026 20:53:49 GMT
• Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver... Business Wire Fri, 15 May 2026 07:00:00 GMT
• agenus (agen) principal accounting officer austin charette plans may 2026 exit Stock Titan Fri, 15 May 2026 07:00:00 GMT
• early drug combo yields responses in liver cancer after immunotherapy Stock Titan Fri, 15 May 2026 07:00:00 GMT
• agenus (agen) reports phase 1b results for innovative cancer tre GuruFocus Fri, 15 May 2026 07:00:00 GMT
• vital dialogue with princess dina and garo armen on cold tumor challenge and future of immunotherapy Oncodaily Thu, 14 May 2026 13:14:39 GMT
• first quarter 2026 was a defining quarter for bot and bal – agenus Oncodaily Thu, 14 May 2026 02:58:23 GMT
• Agenus' Comeback Quarter: From SEC Closure to Phase 3 Launch, BOT+BAL Enters Its Defining Year Oncodaily Wed, 13 May 2026 07:00:00 GMT
• first quarter 2026 was a defining quarter for bot and bal – agenus Oncodaily Wed, 13 May 2026 07:00:00 GMT
• agenus buy rating reaffirmed as late-stage strategy advances; $23 price target maintained TipRanks Tue, 12 May 2026 12:00:35 GMT
• h.c. wainwright maintains agenus(agen.us) with buy rating, maintains target price $23 富途牛牛 Tue, 12 May 2026 10:31:00 GMT
• advancing strategies to activate and sustain immune response in harder-to-treat cancers - agenus Oncodaily Tue, 12 May 2026 07:00:00 GMT
• agenus reports q1 results, phase 3 trial enrollment begins by investing.com Investing.com Australia Tue, 12 May 2026 01:57:35 GMT
• is agenus (agen) undervalued after q1 2026? revenue $33.7m (miss GuruFocus Mon, 11 May 2026 23:03:45 GMT
• agenus inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 21:04:00 GMT
• agenus announces conclusion of sec investigation with no enforcement action TipRanks Mon, 11 May 2026 15:50:48 GMT
• immuno-oncology developer agenus' q1 revenue rises, posts profit TradingView Mon, 11 May 2026 12:53:56 GMT
• Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development Business Wire Mon, 11 May 2026 07:00:00 GMT
• Agenus (AGEN) Releases Q1 2026 Earnings: Revenue Growth but EPS Miss | AGEN Stock News Quiver Quantitative Mon, 11 May 2026 07:00:00 GMT
• AGENUS INC 1Q 2026: Revenue $33.7M, EPS $1.02— 10-Q Summary TradingView Mon, 11 May 2026 07:00:00 GMT
• Agenus Inc reports results for the quarter ended March 31 - Earnings Summary TradingView Mon, 11 May 2026 07:00:00 GMT
• agenus reports q1 results, phase 3 trial enrollment begins Investing.com Mon, 11 May 2026 07:00:00 GMT
• agenus (agen) reports significant increase in cash reserves GuruFocus Mon, 11 May 2026 07:00:00 GMT
• zydus collaboration lifts agenus (nasdaq: agen) to q1 2026 profit Stock Titan Mon, 11 May 2026 07:00:00 GMT
Agenus Inc(NASDAQ:AGEN)
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and displa...
Website: http://agenusbio.com
Founded: 1994
Full Time Employees: 328
Sector: Healthcare
Industry: Biotechnology
